All Activity

I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. Slot Thailand

What a fantabulous post this has been. Never seen this kind of useful post. I am grateful to you and expect more number of posts like these. Thank you very much. Jadwal Bola Malam Ini

Nice post! This is a very nice blog that I will definitively come back to more times this year! Thanks for informative post. Lapak303 Poker

“There are a lot of other details surrounding cannabis that have been discussed and will continue to be discussed.” By Christine Zhu, NC Newsline North Carolina lawmakers are considering banning individuals under 21 from buying or possessing certain hemp-derived consumable products, including smokable hemp flower, hemp cigarettes, gummies and beverages, or any items that include the drug kratom. The House Agriculture and Environment Committee approved a rewrite of Senate Bill 59 on Wednesday. It’s the latest attempt by state lawmakers to regulate the sale of hemp products after years of proposals that ultimately didn’t succeed. The measure would prohibit businesses from selling these products to those under 21. If a seller has “reasonable grounds” to believe the prospective buyer is under 21, the seller must check the buyer’s ID. Rep. Jimmy Dixon (R-Duplin), who presented the bill, said he was motivated to draw public attention to issues surrounding cannabis. He said there was a 14-year-old in his district who wound up in the emergency room after purchasing a hemp-derived product. “There are a lot of other details surrounding cannabis that have been discussed and will continue to be discussed, but ladies and gentlemen, to be sure we’ve got the good sense to be an agent on these types of problems, that is the lowest hanging fruit there is,” he said. Those found in violation of the measure would face a Class 2 misdemeanor as well as a $500 fine for a first offense, $1,000 for a second offense and $1,500 for subsequent offenses. Rep. Pricey Harrison (D-Guilford) asked if the bill’s language accounted for potential modifications to hemp-derived products. It’s common for makers of synthetic recreational drugs to make changes to their products’ chemical makeup to get around legal bans or restrictions. “I assume the way the definition is as written is broad enough that it captures any future manipulation of molecules,” she said. Dixon nodded in the affirmative. Legislators also voted in favor of an amendment to add kratom products to the under-21 ban. Rep. Jeffrey McNeely (R-Iredell), who proposed the amendment, said he felt it was necessary to add those items to the bill. “I’ve worked on this for quite a while now, trying to put forth these bills,” McNeely said. “We’ve definitely got a problem. So I hope we keep bringing this to light, and we get something accomplished before we get out of short session here.” Both the amendment and the legislation passed unanimously without debate. The bill moves next to the House Rules Committee. Other amendments will be heard when it appears on the House floor, which could be as soon as next week. This story was first published by NC Newsline. The post North Carolina Lawmakers Advance Bill To Set A Minimum Age Limit For Hemp And Kratom Products appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Document thrilled along with the researching you will designed to makes precise put up impressive. Delightful adventure! 인디고 게임

A detailed and reader-friendly post with clear explanations. The step-by-step presentation makes it easier to understand. While researching Escorts in Delhi, your blog provided helpful and practical guidance.

“I do not support expanding the cultivation of marijuana in our state.” By William Skipworth, New Hampshire Bulletin Gov. Kelly Ayotte (R) quashed a bipartisan effort to make medicinal marijuana more affordable and available in New Hampshire. Senate Bill 468, sponsored by Loudon Republican Sen. Howard Pearl, would allow medicinal marijuana dispensaries to have their own greenhouse on site. The idea is to increase supply and lower prices. Each dispensary would be limited to one greenhouse to grow their own cannabis. Ayotte vetoed the bill on Friday. “I do not support expanding the cultivation of marijuana in our state,” she wrote in her veto statement. “For this reason, I have vetoed SB 468.” New Hampshire legalized marijuana for medical use in 2013 while Maggie Hassan was governor. The law limits people to two ounces of marijuana and allows only a designated group of providers. The only dispensaries in the state are in Chichester, Conway, Dover, Keene, Lebanon, Merrimack and Plymouth, and they’re all operated by one of four nonprofit “alternative treatment centers.” New Hampshire residents need a medical marijuana card issued by a physician to shop at any of them. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — New Hampshire is the only New England state that hasn’t legalized recreational marijuana. Nationwide, 24 states have legalized the drug for recreational purposes and 39 for medical use. Ayotte has repeatedly opposed recreational legalization in New Hampshire, citing multiple factors. She’s worried about the fact that police are unable to measure a driver’s level of marijuana intoxication using current technology like they can with alcohol. She has also cited youth mental health and “quality of life.” It would take a two-thirds vote in both the House and Senate to override Ayotte’s veto. The Legislature will meet later this year to vote on whether to do so. This story was first published by New Hampshire Bulletin. Unrelated context excised by Marijuana Moment. Photo courtesy of Chris Wallis // Side Pocket Images. The post New Hampshire Governor Vetoes Bill To Allow Medical Marijuana Cultivation In Greenhouses appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

That i taken aback when using the exploration everyone intended to get this to selected present astounding. Terrific process! AK 게임

It is my first visit to your blog, and I am very impressed with the articles that you serve. Give adequate knowledge for me. Thank you for sharing useful material. I will be back for the more great post. situs toto

this is really nice to read..informative post is very good to read..thanks a lot! 강남가라오케

I have bookmarked your blog, the articles are way better than other similar blogs.. thanks for a great blog! koitoto

Wow, cool post. I'd like to write like this too - taking time and real hard work to make a great article... but I put things off too much and never seem to get started. Thanks though. แทงบอลสด

The governor of Illinois has signed a large-scale cannabis omnibus bill into law that doubles the amount of marijuana that adults can legally possess, significantly restricts hemp THC products and makes other changes to rules for how licensed businesses can operate. Gov. JB Pritzker on Friday gave final approval to the legislation, which cleared the House of Representatives and Senate about two weeks ago. As enacted into law, SB 3222 allows residents of the state who are over 21 years of age to possess up to 60 grams of marijuana flower—double the amount in prior law. They are also able to have up to 10 grams of cannabis concentrates and infused products with up to 1,000 mg of THC—also double the earlier limit. Possession amounts for adult non-residents are also doubled under the bill. People with past convictions for possession of up to 60 grams of marijuana will now be able to have those records expunged—double the previous cutoff allowing only those with convictions for up to 30 grams to be eligible. The legislation also recriminalizes hemp THC products with more than 04. milligrams of THC per container, in line with a federal ban that is set to take effect in November. “Instead of letting an ambiguous marketplace keep putting people at risk, Illinois is taking action to protect consumers of all ages, especially children, from misleading packaging and labeling,” Pritzker said in a press release. “This landmark legislation closes the intoxicating hemp loophole while bolstering equity and oversight and expanding medical access. Illinois is committed to cultivating a cannabis industry that benefits diverse businesses across the state and prioritizes accessibility, and I am proud to sign this measure into law.” Illinois continues to set the standard for opportunity, equity, and safety in the adult legal cannabis industry. Today, I’m signing legislation to ban the sale of intoxicating hemp to those under 21 to protect our kids, streamlining licensing, and strengthening oversight. pic.twitter.com/HEnEdSWe7e — Governor JB Pritzker (@GovPritzker) June 12, 2026 Among other changes, the bill also allows drive-thrus and curbside pickup at dispensaries, permits them to stay open until 2 a.m. and makes it so medical cannabis certifications can be issued via telehealth. Canopy limits for craft cannabis cultivators will be expanded form 5,000 to 14,000 square feet, and the new law loosens some security requirements for marijuana businesses while also waiving or reducing fees for smaller operators. In 2019, Pritzker signed the state’s initial marijuana legalization policy into law. While the broader restrictions on hemp products take effect in the state on November 12 in conjunction with the similar federal move, sales to people under 21 are prohibited immediately, The legislation separately allows all marijuana dispensaries to register to sell medical cannabis specifically. The list of medical marijuana qualifying conditions is also being expanded to add female orgasmic disorder, endometriosis, ovarian cysts and uterine fibroids. “Illinois has led the nation in building a cannabis industry that prioritizes both equity and public safety, and SB 3222 builds on that progress,” Lt. Gov. Juliana Stratton said. “By protecting young people from unregulated intoxicating hemp products and creating clear standards for the industry, we are ensuring consumers are safer while preserving opportunities for diverse businesses and communities across our state.” Photo courtesy of Mike Latimer. The post Illinois Governor Signs Bill To Double Marijuana Possession Limit, Restrict Hemp THC Products And Reform Rules For Businesses appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“The proposed measure does not place voters in ‘the untenable position of casting a single vote on two or more dissimilar subjects.'” By Chris Lisinski, CommonWealth Beacon A controversial push to revoke recreational marijuana legalization remains on track to be decided by voters after the state’s highest court on Friday rejected a legal challenge seeking to toss the measure. The Supreme Judicial Court ruled that the attorney general’s office properly certified and summarized the question, whose campaign is funded by a national dark-money group fighting legal drug use in multiple states. If organizers collect enough signatures this month—which is nearly guaranteed given that the final haul required is far less than an earlier signature threshold—the measure will lock in a spot on the November ballot, tasking Bay Staters with choosing whether to walk back their 2016 vote to legalize and launch a multibillion-dollar recreational cannabis industry. The campaign has been fraught with controversy, both over the policy particulars and over the route taken. Earlier this year, opponents alleged that the campaign obtained signatures “fraudulently” by misleading voters and describing the question as related to affordable housing or funding public parks. The State Ballot Law Commission dismissed the challenge. The lawsuit before the SJC took another approach. In that case, plaintiffs argued that Attorney General Andrea Campbell’s (D) office should have deemed the question ineligible because it combined unrelated topics and would allow a “taking of private property without providing compensation.” They also contended that the AG’s summary failed to communicate to voters that the ballot question would eliminate marijuana industry social equity grants—which the plaintiffs themselves received—and some cannabis-related penalties. Justices disagreed. The question’s “limited effects on the regulation of medical marijuana” do not rise to an improper comingling of discrete topics, Justice Elizabeth Dewar wrote in the decision. The sections of the ballot measure that would eliminate social equity programs and mandatory host community agreements “all bear an operational relationship” to the proposal’s primary goal, she added. “As the plaintiffs argue, there indeed may be voters who favor restricting recreational marijuana but do not favor eliminating these other aspects of the current regulatory regime in relation to medical marijuana,” Dewar wrote. “Nonetheless, the proposed measure does not place voters in ‘the untenable position of casting a single vote on two or more dissimilar subjects.’” The court also ruled that the AG’s written summary is sufficient, even with a broad generalization of the existing laws the question would repeal. Justices noted, as case law has found, that “the summary is not the only source of information for voters”—a line that could play a role in a forthcoming decision about a ballot question seeking to cut the income tax rate, which also faces an eligibility challenge hinging on the official summary. Three other SJC decisions on ballot questions are expected in the coming weeks: the income tax cut, a measure seeking to revive rent control with a strict statewide cap, and a proposal to place all primary election candidates on a single ballot regardless of party. Those rulings, plus ongoing talks about compromise legislation that could replace ballot questions, will decide the final size of the field this November. If every proposal advances to the ballot, it would be a record 11 questions. This article first appeared on CommonWealth Beacon and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License. Photo elements courtesy of rawpixel and Philip Steffan. The post Massachusetts Supreme Court Rejects Challenge To Marijuana Legalization Rollback Ballot Initiative appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Nice post! This is a very nice blog that I will definitively come back to more times this year! Thanks for informative post. bandar togel

I like your post. It is good to see you verbalize from the heart and clarity on this important subject can be easily observed... gurutoto

Virginia’s governor and a key lawmaker say they have reached an agreement on a proposal to legalize recreational marijuana sales through budget legislation this month following the veto of a previous proposal to enact the reform. “Throughout this year’s legislative process, my end goal has been to finally set up a safe, well-regulated retail cannabis market in Virginia,” Gov. Abigail Spanberger (D) said on Friday, adding that she is “grateful” to lawmakers who have led on the issue “for their partnership in delivering a new framework to move forward in a way that is paced appropriately for regulators, public health officials and law enforcement.” “I look forward to sharing more specific details soon,” she said. Del. Paul Krizek (D), who sponsored the earlier measure to allow adult-use cannabis commerce and is serving as a negotiator for the budget, said on Friday that “we have a deal” on the marijuana issue. He was speaking a a press conference where House leaders unveiled their broader budget proposal, which includes cannabis reform language. Krizek said that lawmakers and Spanberger would hold a separate press conference on Tuesday focused on unveiling full details of the negotiated marijuana compromise. For now, the cannabis provisions in the House budget legislation are marked as a “placeholder” and do not necessarily reflect the final deal—though there are some notable changes from the previously passed and vetoed measure that appear to reflect certain areas of agreement between the governor, Krizek and Sen. Lashrecse Aird (D), who sponsored the Senate version of the earlier bill. For example, the new legislation sets the launch date for recreational marijuana sales at July 1, 2027, which is what Spanberger proposed in contrast to the January 1 date in what lawmakers had passed. It also sets the legal public marijuana possession and per-transaction purchase limit at 2 ounces, an increase from the current legal limit of one ounce. The legislation lawmakers passed earlier this year would have allowed adults to possess up to 2.5 ounces. The bill also cedes to Spanberger on language to increase a marijuana excise tax from 6 percent to 8 percent after two years of legal sales. By way of compromise, the new legislative text would make public consumption of marijuana punishable by a civil penalty of $250—a significant increase from the $25 in current law but less harsh than the class 4 criminal misdemeanor the governor sought in her proposed changes to the previous bill. The House budget legislation also provides a significant increase in funding for the Virginia Cannabis Control Authority to address “costs associated with the creation of a retail cannabis market.” Delegate Paul Krizek says “we have a deal” on a legal recreational marijuana market in the budget. He says there will be a press conference with Governor Spanberger next week unveiling the agreement. pic.twitter.com/kY1VofId5p — Tyler Englander (@TylerEnglander) June 12, 2026 Lawmakers passed the cannabis sales bills in March, but the governor then suggested changes to the legalization proposal—including delaying the start date for sales by six months, increasing taxes and instituting new criminal penalties for cannabis consumers. The legislature in April declined to take up the amendments during a one-day reconvened session, however, effectively rejecting them. Spanberger then issued a veto. Spanberger said earlier this week that she has been having “really productive” and “incredible” conversations with lawmakers about crafting a compromise approach to legalizing adult-use cannabis sales, and Marijuana Moment previoulsy reported on the ongoing talks. A spokesperson for Spanberger previously told Marijuana Moment that the governor “has made clear that she continues to support setting up a legal retail marketplace for cannabis that prioritizes the health and safety of Virginians, protects communities and consumers and operates with clear enforcement and regulatory authority.” The governor and the sponsors of the legalization legislation “share these same goals, and she looks forward to moving this across the finish line together,” the spokesperson said. Following Spanberger’s veto, top lawmakers have been openly discussing the possibility of including provisions to legalize adult-use cannabis sales in still-outstanding budget legislation that they are due to pass by July 1. The effort to keep the issue alive was a topic of discussion last week at the first meeting of the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market since the governor’s move to kill the previous proposal to regulate adult-use marijuana sales. The governor, meanwhile, is continuing to try to publicly explain her veto—including by saying it is her view that “taking a little bit longer” to launch the market is not something she sees as “negative” because it is more important to get the details right than to do it fast. A recent survey found that bipartisan majorities of Virginia voters wanted Spanberger to sign the cannabis legislation into law, and that they specifically disagreed with her desire to slow the launch timeline for legal sales. The governor recently acknowledged in a separate interview that “a lot of people are not pleased” with her veto of the cannabis legislation. “Friends and family are displeased as well,” she said. Spanberger has repeatedly responded to criticism of her cannabis amendments from the bill sponsors and advocates by saying the suggested changes came after she spoke to the leaders of other states that have already implemented adult-use marijuana markets. A spokesperson for Spanberger declined to name any other governors she talked to about cannabis in response to a question from Marijuana Moment, however. The governor separately recently sought to explain her veto in an earlier interview, reiterating that she supports launching a legal cannabis market but worried about what she called a “rushed timeline” and “far more stores across Virginia” than she thinks are appropriate. Prior to vetoing the cannabis commerce bill, the governor did sign separate legislation to provide resentencing relief for people with past cannabis convictions. Personal marijuana possession and home cultivation of marijuana has been legal in Virginia since 2021, but then-Gov. Glenn Youngkin (R) twice vetoed bills to provide consumers with a way to legally purchase regulated adult-use cannabis. Aird and Krizek, the sponsors of the legalization bills, had urged colleagues to vote against the governor’s amendments—even if that meant risking a veto from Spanberger when the legislation returned to her desk, which has now occurred. Here are the other key details of the cannabis bills—SB 542 and HB 642—as approved by lawmakers and with the governor’s suggested amendments prior to the newly negotiated compromise: Lawmakers voted to allow adults to be able to purchase up to 2.5 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products as determined by regulators. That would represent an increase from the limit in current law of 1 ounce. The governor, however, wanted the amount increased to only 2 ounces. Under the legislature’s plan, legal sales could begin on January 1, 2027, but the governor proposed to push that back to July 1, 2027. Lawmakers voted to impose an excise tax of 6 percent on cannabis sales as well as a 5.3 percent retail sales and use tax, while allowing municipalities to set an additional local tax of up to 3.5 percent. The governor’s plan was largely the same, though it would have increased the excise tax to 8 percent starting on July 1, 2029. Under the legislation as approved by lawmakers, revenue would have been distributed to the Cannabis Equity Reinvestment Fund (30 percent), early childhood education (40 percent), the Department of Behavioral & Developmental Health Services (25 percent) and public health initiatives (5 percent). The governor, however, wanted to put all revenue into the general fund while earmarking it “for purposes such as early childhood education, behavioral health, public health awareness, prevention, treatment, and recovery services, workforce development, reentry, indigent criminal defense, and targeted reinvestment in historically disadvantaged communities.” The Virginia Cannabis Control Authority would have overseen licensing and regulation of the new industry, and would have also taken on oversight of hemp, which is currently under the Department of Agriculture and Consumer Services. Local governments could not have opted out of allowing marijuana businesses to operate in their area. Delivery services would have been allowed. Serving sizes would have been capped at 10 milligrams THC, with no more than 100 mg THC per package. The governor proposed to make public marijuana use a class 4 criminal misdemeanor instead of civil violation punishable by a $25 fine as under current law. She also wanted to make possessing cannabis by people under the age of 21 a class 1 misdemeanor, punishable with a mandatory minimum fine of $500 or 50 hours of community service, as well as the suspension of drivers licenses for at least six months. Illegally selling or distributing 50 pounds or more of marijuana would have been a class 2 felony punishable by life in prison. The governor sought to eliminate support for the Cannabis Equity Reinvestment Fund. Existing medical cannabis operators could have entered the adult-use market if they pay a licensing conversion fee that was set at $10 million. Cannabis businesses would have had to establish labor peace agreements with workers. As passed by lawmakers, the bill would have directed a legislative commission to study adding on-site consumption licenses and microbusiness cannabis event permits that would allow licensees to conduct sales at venues like farmers markets or pop-up locations, but the governor proposed to remove that language. A coalition of cannabis reform organizations sent the governor a letter urging her not to veto the sales legalization legislation even though her amendments were rejected. “Together, these bills address the real issues surrounding cannabis in the Commonwealth today: an already-existing, unregulated marijuana market operating openly across the state while consumers, communities, and law enforcement are left without the protections of a legal framework,” the groups wrote. “Let’s be clear: these bills do not create a marijuana market in Virginia. That market already exists,” the letter said. “What these bills do is replace today’s predatory and unaccountable illicit operators with a regulated marketplace, enforceable rules, oversight, product safeguards, age verification, and the strict consumer safety standards already in use for Virginia medical cannabis.” The letter was signed by Virginia NORML, Marijuana Justice, Virginia Cannabis Association, Marijuana Policy Project and other groups. Separately, a coalition of hemp businesses that joined with a major alcohol retailer in asking Spanberger to veto the marijuana bill before she did so said the move presents an “opportunity” to craft better cannabis policy. Meanwhile, the governor signed several other reform bills this session—including measures to protect the parental rights of marijuana consumers and allow patients to access medical cannabis in hospitals. Read the House budget legislation with cannabis provisions below: The post Virginia Lawmakers And Governor ‘Have A Deal’ On Bill To Legalize Marijuana Sales This Month appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Democratic congressman has filed a new bill that would drastically overhaul how drugs are classified under the Controlled Substances Act (CSA), including by letting states effectively force federal rescheduling by changing their own local laws. Under current law, federal officials conduct a multi-part analysis to determine which, if any of CSA’s five schedules to place drugs in—depending on factors such as their medical use, potential for abuse and safety or dependence liability. But advocates have complained that those criteria are ambiguous and that the Drug Enforcement Administration (DEA) often refuses to acknowledge widely accepted medical value of substances—pointing out that it has taken more than half a century to begin moving marijuana out of Schedule I, the most restrictive category—a process that is now underway due to a review initiated during the Biden administration and that is advancing under President Donald Trump. The new Controlled Substances Act Clarification in Sciences Act, filed this week by Rep. Steven Cohen (D-TN), would more clearly define in statute some of the criteria that officials with DEA and federal health agencies use to determine drugs’ scheduling status. A major change under the bill would define “accepted medical use” to include any use where “a jurisdiction has authorized the drug or substance for medical use,” “the drug or substance is widely used in such jurisdiction by health care practitioners” and “such legitimate medical use is recognized by the entities that regulate the practice of medicine in such jurisdiction through evidence-based scientific evaluation that employs rigorous and generally accepted methodologies.” Because drugs that have a currently accepted medical use cannot be classified under Schedule I, the reform contemplated by the bill would effectively mean that jurisdictions within the U.S., could force federal rescheduling of a drug by legalizing it for widespread medical use and having it recognized by local regulators. When the Department of Health and Human Services (HHS) conducted its analysis of marijuana rescheduling under the Biden administration, it attributed significant value to the fact that medical cannabis is so widely used under a growing number of state laws. Legalization opponents criticized that move and suggested it was an improper change in how scheduling status has historically been analyzed, but the new bill would effectively codify it. “Accuracy in federal drug policy will ensure both fairness and safety. Much has changed since 1970 when the Controlled Substances Act was enacted,” Cohen said in a press release. “My bill will clarify and update the CSA so that the evaluation of controlled substances is made on the best scientific evidence of today, not decades-old processes and outdated knowledge.” This week I introduced the Controlled Substances Act (CSA) Clarification in Sciences Act — legislation to ensure that decisions about controlled substances are based on today’s best scientific evidence, not outdated standards. For too long, the law has boxed promising treatments… pic.twitter.com/oYK7wmsGWz — Steve Cohen (@RepCohen) June 12, 2026 The legislation, H.R. 9186, would also define terms such as “physical dependence,” “potential for abuse,” “lack of accepted safety for use of the drug or other substance under medical supervision” and “potential benefits to society,” among others. It would additionally add a provision to the CSA clarifying that the attorney general must “defer to” the health and human services secretary’s “scientific and medical evaluation of a drug or other substance.” The official could “add or transfer a drug or other substance to a schedule only if such schedule best corresponds to controls reasonably tailored to protect public health and safety (including the potential for abuse and dependence liability of the drug or substance) while preserving access for accepted medical uses, and recognizing the potential benefits to society, of the drug or substance,” the bill says. A summary of the legislation from Cohen’s office says the bill will help address what it calls a “Schedule I ‘trap'” under which DEA has argued that drugs need Food and Drug Administration (FDA) approval in order to have a currently accepted medical use, but that Schedule I status has limited the very research that is needed to demonstrate such value. “This circular policy can trap substances in Schedule I, driving researchers from the field and reduce the number of FDA-approved medicines, especially those for mental health disorders,” it says. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Cohen said he “worked diligently with the nation’s leading scientific professional societies to ensure the bill’s approach reflects the gold standards in biomedical research and contemporary healthcare.” The legislation is endorsed by scientific societies such as the American College of Neuropsychopharmacology, American Society of Clinical Psychopharmacology, American Society for Pharmacology and Experimental Therapeutics and Society of Biological Psychiatry. “Therapeutic progress depends directly on the ability of physicians and researchers to study substances of interest,” the congressman said. “The current law’s imprecise approach to scheduling substances has created a system that is arbitrary and largely ignores the modern practice of medicine and public health, and has substantially hindered scientific progress.” Deanna Barch, president of the American College of Neuropsychopharmacology, said the measure “takes a long-needed step to enhance clarity and strengthen the scientific basis on which substances are reviewed for scheduling.” “By adding and updating critical definitions that the statute has lacked, it gives the administering agencies a sounder evidentiary foundation for their evaluations,” she said. “The scheduling framework these terms support has stood since the Controlled Substances Act was enacted in 1970, and bringing its core definitions into line with current science is an important and welcome advance.” Randy Hall, president of the American Society for Pharmacology and Experimental Therapeutics, added that the bill “addresses a barrier the research community has faced in studying controlled substances.” “In many cases, the constraints of scheduling status prevent scientists from understanding whether a substance may, in fact, have medical utility,” he said. “These updates will facilitate the investigation of the use of many substances in a variety of therapeutic areas.” Society of Biological Psychiatry President Dost Öngür noted that “for too long, the law has trapped promising treatments in a circular standard that blocks the very research needed to prove their value.” “By insisting that drug scheduling rest on evidence, this legislation reopens the door to discovery for the millions of Americans living with depression, PTSD, and other serious psychiatric conditions,” he said. Brooke Shockey Sanders, director of network relations for Students for Sensible Drug Policy (SSDP), said that “as a Neuroscience PhD researcher studying Schedule I drugs, the Controlled Substances Act (CSA) has shown to be the biggest barrier in my scientific advancement.” “Representative Cohen’s clarification of the CSA would allow for scientists, like myself, to conduct more cost effective, timely and accurate medical research of drugs currently confined by legal barriers,” she said. “This revision is promising for the future of medical advancement, allowing for development of novel therapeutic for diseases with large global prevalence rates.” The post New Bill In Congress Would Let States Force Federal Reclassification Of Drugs Like Marijuana And Psychedelics appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Ukraine’s Ministry of Health has announced that the country’s medical cannabis program is officially operational, with the first prescribed products being purchased by a handful of patients on Thursday. The THC capsules were dispensed at a pharmacy in the city of Vinnytsia to two veterans suffering from chronic neuropathic pain and phantom limb pain following amputation and a woman with multiple sclerosis. Officials said that medical cannabis-based medicines are now available for purchase at six pharmacies belonging to a single licensed entity in Vinnytsia, Dnipro, Lviv, Ivano-Frankivsk, Ternopil, and Khmelnytskyi—with about 17 more pharmacies expected to launch sales soon. The State Service of Ukraine on Medicines and Drugs Control said that “patients living with severe pain daily and requiring modern treatments now have an additional option to access modern pharmacotherapy.” “The manufacture and dispensing of medical cannabis-based medicines may be carried out by business entities holding licenses for the production, wholesale and retail trade and import of medicinal products (except for active pharmaceutical ingredients), as well as a license for activities involving narcotic drugs, psychotropic substances, and precursors,” the health ministry said. “In addition to the license, to compound such medicines in a pharmacy, business entities must also obtain a quota.” About 36 public and 30 private entities hold the relevant cannabis-related licenses across 180 practice locations, the government said. President Volodymyr Zelensky signed Ukraine’s medical cannabis legalization legislation into law in 2024, shortly after lawmakers approved the measure. About a year ago, officials granted the first-ever license allowing for imports of cannabis into the country. The law as written legalized medical cannabis for patients with severe illnesses and post-traumatic stress disorder (PTSD) resulting from the nation’s ongoing conflict with Russia, which launched an invasion of Ukraine. While the text of the legislation as introduced listed only cancer and war-related PTSD as qualifying conditions, the chair of the health committee said in July that lawmakers were hearing daily from patients with other illnesses such as Alzheimer’s disease and epilepsy. The Ministry of Health has since approved conditions such as chronic or neuropathic pain, spasticity, for nausea and vomiting due to chemotherapy in cancer treatment and Parkinson’s disease, among others. Lawmakers first approved the medical cannabis legislation in late 2023, but the opposition Batkivshchyna party used a procedural tactic to block it by forcing consideration of a resolution to repeal the measure. That resolution failed, clearing its path to enactment. Opponents previously tried to derail the marijuana bill by filing hundreds of what critics called “spam” amendments, but that attempt similarly failed, with the measure ultimately passing with 248 votes. Officials in 2024 moved to clarify the scope of the new program. “Cannabis, its resin, extracts and tinctures are excluded from the list of particularly dangerous substances,” the Ministry of Health said in an announcement at the time. “Previously, their circulation was prohibited—now it is allowed, but with certain restrictions.” The Agrarian Policy Ministry holds regulatory responsibilities over cannabis cultivation and processing operations. The National Police and State Agency on Medicines also holds oversight and enforcement authorities related to the distribution of the medicine. Zelensky, for his part, voiced support for medical marijuana legalization in mid-2023, stating in an address to the parliament that “all the world’s best practices, all the most effective policies, all the solutions, no matter how difficult or unusual they may seem to us, must be applied in Ukraine so that Ukrainians, all our citizens, do not have to endure the pain, stress and trauma of war.” “In particular, we must finally fairly legalize cannabis-based medicines for all those who need them, with appropriate scientific research and controlled Ukrainian production,” he said. Zelensky also spoke in support of medical cannabis legalization during his presidential campaign, saying in 2019 that he feels it would be “normal” to allow people to access cannabis “droplets,” which is possibly a reference to marijuana tinctures. The policy change puts Ukraine is stark contrast to its long-time aggressor Russia, which has taken a particularly strong stance against reforming cannabis policy at the international level through the United Nations. The country has condemned Canada for legalizing marijuana nationwide, for example. WNBA player Brittney Griner served time in a Russian prison over possession of cannabis oil that she also lawfully obtained as a medical marijuana patient in Arizona before being released as part of an earlier prisoner swap that the Biden administration negotiated. In 2025, Russia arrested and then later freed a 28-year-old American citizen who was facing charges over alleged possession of cannabis after authorities reportedly found cannabis products in his luggage at a Moscow airport. The post Ukraine’s First Legal Medical Cannabis Products Have Been Dispensed To Military Veterans And A Woman With MS appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The Trump administration’s move to federally reschedule marijuana opens the door to interstate cannabis commerce—and it could happen through one of several unique pathways—according to a leading advocacy group. The Marijuana Policy Project (MPP) said in a recent analysis that it’s closely monitoring the implications of a Justice Department order that moved medical cannabis authorized by states from Schedule I to Schedule III of the Controlled Substances Act (CSA)—reasoning that “interstate commerce between licensed businesses would thus also be presumably federally legal” under the federal reform. While the rescheduling order’s immediate focus is on state-authorized medical cannabis—and its federally legal status may be contingent on registration with the Drug Enforcement Administration (DEA)—MPP said it’s expecting to see the new policy put to the test, particularly as it concerns possible medical cannabis expansion and interstate commerce opportunities. One of the direct impacts of rescheduling is that the limited number of states that don’t already have a law allowing medical marijuana use “will be under some pressure to adopt one,” MPP said. Some states, like South Carolina, for example, have statutes on the books where federal rescheduling triggers mandatory state-level reform. In some of those places, however, “there’s little political appetite…for legalizing commercial cannabis production,” the group said. But there may be ways to implement a policy change without creating significant political friction, thanks to the interstate commerce opportunities presented by federal rescheduling. “A medical program that specifically envisions legal product from out of state would lessen the state’s regulatory burden (they could regulate retail alone if they chose, or even limit sales to pharmacies), sidestep political resistance to commercial production, and get legal, tested, high-quality cannabis into patients’ hands sooner and less expensively than a state-gated program,” the group said, adding that it’s also “possible we’ll see a push to open commerce in some ‘established’ medical states with inadequate patient access.” “MPP will work over the coming year to identify and help lead efforts in currently non-medical or quasi-medical states to adopt and approve patient-centered programs specifically anticipating commerce, allowing patients to access the best and most affordable medical cannabis available as soon as possible.” Next, federal rescheduling is likely to lead states with established and well-regulated medical marijuana markets to allow for interstate cannabis imports and exports, MPP said. The legislative infrastructure for such a commercial market has already been created in several states—including California, Oregon and Washington State. Such interstate commerce laws are generally written in a way that requires federal legalization or explicit guidance to prevent federal enforcement action, but modest tweaks to the policies could open the doors to imports and exports between legal states if the right conditions are met under rescheduling. “MPP stands ready to work with allies in those and other states seeking to pass legislation allowing their medical licensees—operating in compliance with federal requirements—to ship products to states whose medical programs allow it,” it said. Check out our new blog to get the facts on what rescheduling means for medical interstate commerce, and see how MPP is working to keep patients protected!https://t.co/rsGPZ94CYf — Marijuana Policy Project (@MarijuanaPolicy) May 29, 2026 In California, the attorney general previously said no such federal permission exists to allow for interstate marijuana commerce agreements, but advocates have recently raised questions about whether that could change given the Trump administration’s rescheduling move. Attorney General Rob Bonta’s (D) office told Marijuana Moment last week that the state “DOJ does not have a public policy concerning updating prior Attorney General opinions,” but the attorney general “has at times reevaluated past opinions in response to a subsequent request from a person that is authorized to request AG opinions.” Finally, MPP said in its post that supporters should expect to see a “successful” federal lawsuit as it concerns the Dormant Commerce Clause (DCC) of the U.S. Constitution. That clause has been at the center of multiple prior cases related to the marijuana industry, but with federal rescheduling there will likely be added impetus for courts to reach consensus and find that the exclusivity of intrastate marijuana markets runs counter to the Constitution, the group said. “DCC protection would bar states with legal markets from discriminating against legal products from other states,” MPP said. “The federal decisions finding no DCC protection have leaned on cannabis’s federal illegality. The Final Order almost certainly changes that for licensed medical operators.” “We expect stakeholders to sue states in multiple federal circuits (hoping to consolidate those into one suit), seeking to force open state markets on constitutional grounds. Interstate commerce in Schedule III drugs between DEA-approved entities is clearly covered by the DCC. A federal case will take time, but assuming rescheduling stands, we expect federal litigation to be ultimately successful.” MPP added that it “has no plans to be involved in federal lawsuits seeking to open existing medical markets to commerce.” To the organization’s point, an Oregon marijuana business last year filed a federal lawsuit against the state, challenging the constitutionality of laws prohibiting interstate cannabis commerce. Photo courtesy of Philip Steffan. The post Trump’s Marijuana Rescheduling Move Opens The Door To Interstate Cannabis Commerce, Top Reform Group Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

To achieve extremely high battle potential, players need more experience. To reach the maximum experience level, visit Jacksmith.

Dwarka can feel a bit isolated sometimes, especially if you're staying near the metro station in Sector 10 or 12. I was there for a week, and the hotel room was getting to me. That's when I found this agency. Their Dwarka Escorts sent a girl who was warm, funny, and made me forget I was alone. We ordered food, watched TV, and just talked. No pressure, no awkwardness. Felt like catching up with an old friend. If you're lonely in Dwarka, don't be. Help is a call away.

KY gov slams GOP lawmaker over medical marijuana comments; PA senator blames gov for cannabis bill defeat; MA anti-marijuana petitioner fired Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Before you dig into today’s cannabis news, I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We’re a small independent publication diving deep into the cannabis world and rely on readers like you to keep going. Join us at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW A drug testing industry group and a cannabis-focused biopharmaceutical corporation are asking a federal appeals court to block the Trump administration from moving forward with marijuana rescheduling—claiming that cannabis is a “dangerous drug that destroys lives.” Kentucky Gov. Andy Beshear (D) slammed a top Republican lawmaker for a “complete lack of humanity” after he said law enforcement should prosecute people who act in accordance with a recent executive order to expand medical cannabis access. A Pennsylvania Republican senator whose marijuana and hemp regulatory bill was defeated in a floor vote is blaming Gov. Josh Shapiro (D) for whipping Democratic votes against it—though the governor’s office says he prefers “comprehensive cannabis regulation” including a “revenue-generating adult-use market.” A Massachusetts campaign working to put a measure to roll back marijuana legalization on the November ballot has fired a signature gatherer over “wholly unacceptable” conduct after a video was posted of him seeming to argue that voters who support legal cannabis access should sign the petitions in order to advance or protect reform. / FEDERAL The U.S. Embassy and Consulates in Mexico issued a warning to U.S. citizens traveling for the World Cup that “drug possession or importation of drugs, including medical marijuana, is illegal in Mexico.” The House Financial Services Subcommittee on Oversight and Investigations heard testimony from a Congressional Research Service official about money laundering associated with illicit marijuana cultivation operations. The Senate bill to require federal officials to study hospital emergency room costs due to marijuana use got one new cosponsor for a total of two. / STATES Rhode Island Gov. Dan McKee (D) signed legislation to address residency requirements that have prevented marijuana business licensing from advancing amid litigation. A Virginia delegate said lawmakers should not include provisions to legalize recreational marijuana sales in budget legislation this month. A New York appeals court overturned a preliminary injunction blocking enforcement actions against unlicensed marijuana stores. Regulators separately touted other recent court rulings on cannabis licensing and enforcement issues. Florida regulators are considering changes to medical cannabis advertising and marketing rules. Illinois regulators revised cannabis forms for new accessibility standards. Nevada Cannabis Advisory Commission subcommittees will meet on Tuesday and Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL A Guyanese court dismissed a marijuana trafficking charge against a former lawmaker. / SCIENCE & HEALTH A study found that a “CBD-ASD hydrogel represents a stable, multifunctional delivery platform that overcomes CBD solubility limitations and enhances therapeutic efficacy for inflammatory skin diseases.” A study demonstrated a “stable and clinically meaningful long-lasting antidepressant effect of one or two 25 mg doses psilocybin with adjunct psychotherapy up to twelve months in” treatment-resistant depression. / ADVOCACY, OPINION & ANALYSIS Americans for Safe Access published a guide for states related to the Trump administration’s federal marijuana rescheduling move. / BUSINESS Aurora Cannabis Inc. reported quarterly net revenue of C$84.8 million and a net loss from continuing operations of C$27.6 million. Verano Holdings Corp. completed a 1-for-5 reverse stock split. Glass House Brands Inc. filed a prospectus supplement in connection with an at-the-market distribution program allowing it to sell up to $100 million worth of shares. Innovative Industrial Properties, Inc. announced that its operating partnership, IIP Operating Partnership, LP intends to offer $250 million aggregate principal amount of exchangeable senior notes. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Drug testing industry tries to block cannabis rescheduling (Newsletter: June 12, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A very awesome blog post. We are really grateful for your blog post. You will find a lot of approaches after visiting your post. koitoto

Kentucky’s Democratic governor is calling out a top GOP lawmaker for having a “complete lack of humanity” after he suggested that state law enforcement officials should prosecute people who act in accordance with a recent executive order to expand medical cannabis access. Gov. Andy Beshear (D) signed the order last week to broaden the list of health conditions that make patients eligible to legally obtain medical cannabis. Days later, House Majority Whip Jason Nemes (R) asked Attorney General Russell Coleman (R) to ensure that state agencies “not cooperate” with the governor’s marijuana directive, which he called “unlawful.” “Any organization, any licensee, that participates in this unlawful expansion should be prosecuted,” Nemes said during a legislative committee hearing. “This is not the way forward.” On Thursday, Beshear said signing the cannabis order “was the right thing to do, and it was needed, because in the law they wrote in the name of some medical conditions, but then they wrote some symptoms like pain and nausea, all of which clearly are symptoms” of the specifically named conditions. After the legislature declined to take him up on a suggestion to expand the qualifying condition list this session, Beshear used his authority to make it so patients with 15 additional health disorders—including Parkinson’s disease, HIV/AIDS, sickle cell anemia, fibromyalgia, arthritis and glaucoma—can also be certified for medical marijuana access. “It’s helping a lot of people, and I was really surprised to see an attack from one lawmaker who called on the attorney general to prosecute people dying of a terminal illness for securing medical cannabis,” the governor said on Thursday. “I mean, that’s a complete lack of humanity. It is really low. I mean, an individual with ALS, you want to prosecute? That is certainly not leadership, and even for that individual, is a new record low.” “Sometimes we see people make these threats, and in this current culture, I think they think it’s masculinity, but masculinity isn’t being the bully on the playground. It’s being the person that stands between the bully and the person they’re picking on. That’s my job, to stand in between those bullies and these individuals that have these very serious conditions that are saying, ‘Just give me something that isn’t addictive, that isn’t opioids, and that can help me.’ That’s what I’m going to do as governor. These folks are in real pain, they need help, and they need this safe alternative. Politics should never get in the way of doing what’s right for Kentucky.” Beshear also announced on Thursday that he was rescinding an earlier executive order he issued in 2022 through which he offered to provide pardons for any patients who got into trouble for possessing medical cannabis that they purchased at a legal dispensary in a neighboring state. Kentucky’s medical marijuana program has now progressed to the point where cannabis is “readily available” to patients who need it, the governor said, and so the pardon order will expire as of July 1. “This should give people plenty of time, the rest of the month, if you’re traveling out of state, to contact an eligible practitioner and apply for a medical cannabis card right here in Kentucky,” he said. The more recent executive order on qualifying conditions is a follow up to a medical cannabis legalization law Beshear signed in 2023. At a press conference last week to announce the new medical marijuana order, the governor also said he thinks “it’s time” for broader cannabis decriminalization. He additionally cited the results of a recent study from researchers at the University of Kentucky that linked the availability of regulated medical marijuana dispensaries to lower rates of opioid overdoses. Meanwhile, in addition to urging the legislature to go through the process of expanding the medical marijuana qualifying conditions list, Beshear in February also announced that cannabis gummies are available for purchase in the state’s licensed dispensaries. The governor in January also said he’s “not satisfied” with the time it’s taken to launch the state’s medical marijuana program—but that he anticipates the pace of patient access would “pick up significantly” in 2026. The state’s first medical cannabis dispensary opened in December of last year. The governor, who has long championed cannabis reform, previewed the market launch that month, while making the case that medical marijuana will help thousands of patients find an alternative to opioids for pain management. He made much of crossing a 15,000 patient registration milestone in late October, but that’s evidently grown meaningfully in recent months. Beshear previously acknowledged that “it’s taken longer than we would have liked” to stand up the industry since he signed medical marijuana legalization into law in 2023. In recognition of that delayed implementation, he signed an executive order to waive renewal fees for patients who get their cards so that they don’t get charged again before retailers open. And another order he signed providing protections for qualified patients who obtain medical marijuana outside of Kentucky “will stay in place.” Beshear separately announced last year that the state had launched a new online directory that lets people see where medical cannabis dispensaries will be opening near them. He emphasized that the state has been working to deliver access to patients “at the earliest possible date,” and that involved expediting the licensing process. Last year, the governor also ceremonially awarded the commonwealth’s first medical marijuana cards. Meanwhile, the governor sent a letter to Kentucky’s congressional delegation last year, “urging them to take decisive action to protect the constitutional rights of our law abiding medical cannabis patients” by repealing the federal ban on gun possession by people who use marijuana. That came after bipartisan Kentucky senators filed legislation that similarly called on the state’s federal representatives to take corrective action, which Beshear said he supports but would like to see even more sweeping change on the federal level. The federal Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) warned Kentucky residents in 2024 that, if they choose to participate in the state’s medical marijuana program, they will be prohibited from buying or possessing firearms under federal law. During the November 2024 election, Kentucky also saw more than 100 cities and counties approve local ordinances to allow medical cannabis businesses in their jurisdictions. The governor said the election results demonstrate that “the jury is no longer out” on the issue that is clearly supported by voters across partisan and geographical lines. The post Kentucky Governor Slams GOP Lawmaker For ‘Lack Of Humanity’ Over Push For Medical Marijuana Prosecutions appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net